Tactile Systems Technology (TCMD) Reports 12% Revenue Growth to $329.5M for 2025

Tactile Systems Technology Inc. (NASDAQ:TCMD) is one of the best stocks for beginners with little money in 2026. On February 17, Tactile Systems Technology delivered financial results for 2025, with total revenue rising 12% to $329.5 million. The company concluded the year with a robust cash position of $83.4 million.

During this period, the company acquired Lymphotec to target the large population of undiagnosed lymphedema patients. By integrating Lymphotec’s fluid-monitoring tech into its commercial engine, Tactile aims to enhance patient surveillance and streamline the path to therapy. The CEO noted that 2024 investments in a new CRM system and expanded sales headcount are now driving productivity gains. Additionally, updated Medicare National Coverage Determination criteria have provided a tailwind by allowing certain patients to access the FlexiTouch system more directly.

Despite the positive momentum, Tactile Systems Technology Inc. (NASDAQ:TCMD) issued a balanced outlook for 2026, projecting revenue growth of 8% to 11%. This guidance accounts for a potential short-term headwind: a new Medicare prior authorization requirement for pneumatic compression devices.

Tactile Systems Technology Inc. (NASDAQ:TCMD) is a medical technology company that develops and provides medical devices to treat underserved chronic diseases in the US.

While we acknowledge the potential of TCMD as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 10 Most Profitable Undervalued Stocks to Buy and 11 Best Mining Stocks to Buy According to Wall Street.

Disclosure: None.